2023
DOI: 10.1101/2023.06.10.544468
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Paradoxical effects of Zim3, a CRISPRi effector, on human iPSC-cardiomyocyte electrophysiology

Abstract: We show that Zim3, when used as Zim3-KRAB-dCas9 effector in interference CRISPR, without any guide RNAs, paradoxically upregulates key cardiac ion channel genes in human induced pluripotent stem-cell-derived cardiomyocytes, iPSC-CMs, responsible for healthy resting membrane potential, repolarization of the action potential and electrical transmission of signals. These were found to yield expected functional enhancements consistent with a more mature iPSC-CM phenotype, with anti-arrhythmic properties.

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

1
0

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 21 publications
0
2
0
Order By: Relevance
“…In addition, the Zim3 construct is smaller and therefore packaging for in vivo delivery may be easier. We envision high utility of this effector in future studies after proper baseline characterization 50 .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In addition, the Zim3 construct is smaller and therefore packaging for in vivo delivery may be easier. We envision high utility of this effector in future studies after proper baseline characterization 50 .…”
Section: Discussionmentioning
confidence: 99%
“…For this reason, all comparisons were between scramble gRNA and gRNA against a target of interest. Further baseline characterization of the effects of dCas9-KRAB-Zim3 in human iPSC-CMs, without gRNAs, is provided in a short report 50 . Virally delivered dCas9-KRAB-Zim3 appears to be potent CRISPRi effector, as we show for KCNJ2 as well 49 , and after proper characterization, it will likely find multiple applications in cardiac research.…”
Section: Application Of Crispri Across Different Hipsc-cm Cell Linesmentioning
confidence: 99%